To verify the presence of melatonin receptors in Neu mice, melatonin binding was examined in young mouse mammary glands prior to tumor development after 1 month of treatment (3-month-old females in estrus) and in aged animals after long-term treatment (ages 8.2–11.3 months). This evidence concerns the gene ERBB2 and neoplasm.